menu search

Biomarin: growth drivers remain intact

During Q2 2023, Biomarin Pharmaceutical's revenues for the quarter has reached $595.3 million, a 12% Yo...

October 19, 2023, 11:04 pm

Volitionrx highlights study demonstrating nu.q nets is promising biomarker for septic shock

VolitionRx (NYSE-A:VNRX) has highlighted a recently published paper in Annals of Intensive Care which shows the company's Nu.Q NETs test is a promisin...

October 19, 2023, 9:32 am

Why biomarin (bmrn) could beat earnings estimates again

Biomarin (BMRN) has an impressive earnings surprise history and currently possesses the right combinati...

October 18, 2023, 1:32 pm

Jim jordan won't be speaker on the first vote

It took Kevin McCarthy 15 votes to get elected as speaker so it's not over for Jordan but we'll see how it goes from here. Congress is voting and he's...

October 17, 2023, 5:18 pm

Labcorp (lh) launches biomarker test for alzheimer's disease

Labcorp's (LH) new test, ATN Profile, is likely to accelerate the path to the diagnosis of Alzheimer's disease....

October 13, 2023, 9:46 am

Tiziana life sciences to present ms treatment at ectrims annual congress

Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of Six Non-Active Secondary Progressive MS With N...

October 11, 2023, 9:26 am

Labcorp launches 3-part blood test for alzheimer's

Labcorp on Wednesday began marketing to U.S. physicians the first test for a trio of blood biomarkers i...

October 11, 2023, 7:34 am

Yen weakens as momentum fades, japan shifting currency rhetoric

Japanese Yen is trading on a softer note in Asian session as the rebound witnessed yesterday begins to lose steam. A notable comment from Japan’s Fi...

October 10, 2023, 4:29 am

Bunge (bg)-viterra merger receives shareholders' approval

Bunge's (BG) shareholders have voted in favor of its pending merger of Viterra. The deal, which is subject to cust...

October 6, 2023, 12:47 pm

Renalytix sinks to near year low despite news of strengthening us patents

Renalytix PLC (AIM:RENX) shares fell 12% to 46.09p after it said newly allowed US patents further strengthen the core intellectual property underpi...

October 6, 2023, 4:26 am

Gri bio announces publication of comprehensive invariant nkt (inkt) cell review in frontiers in immunology demonstrating a key role of type 1 inkt cells in modulating various fibrotic conditions

In several murine models of chronic inflammation and fibrosis, as well as in humans, it has been shown that iNKT cells are selectively activated in th...

October 5, 2023, 12:45 pm

Newamsterdam pharma's pioneering pulse on alzheimer's breakthroughs

New clinical data shows the potential of obicetrapib in treating early Alzheimer's disease in patients with the ApoE4 mutation. The Phase IIa trial de...

October 2, 2023, 9:26 pm

Candel therapeutics announces three abstracts accepted for poster presentations at sitc 2023 annual meeting

One clinical poster detailing initial overall survival and immunological biomarker data from the ongoin...

September 27, 2023, 1:40 pm

Mainz biomed to present detailed results of colofuture study at international conference on gastroenterology

Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal c...

September 27, 2023, 8:01 am

Robomarkets integrates with tradingview to enhance trading opportunities

Robomarkets, a European broker company, announces its integration with TradingView, a leading platform ...

September 26, 2023, 9:30 am

Are gene therapy stocks the market's next big winners?

It's not often that you see a company whose main product comes with a price tag of over $2 million, but that's the case with biotechs Bi...

September 25, 2023, 8:06 am

Exclusive: xtb introduces etf-based ‘investment plans’ to lure passive investors

Riding the wave of its successful foray into fractional shares, Polish-based brokerage XTB is setting its sights on a new frontier: passive investment...

September 25, 2023, 4:01 am

Shareholders may want to hold off trading pearson stock just yet

Shareholders in Pearson PLC (LSE:PSON) may want to hold their shares for the medium term rather than buy more stock in the educational publisher follo...

September 20, 2023, 9:31 am

Palomar (plmr) stock gains 18.9% ytd: more room for growth?

Palomar (PLMR) stock gains from the expansion of products' geographic footprint and new partnerships, h...

September 20, 2023, 9:01 am

Pearson falls as ceo steps down

Shares in Pearson PLC (LSE:PSON) fell 5% after it announced a change at the top, with Andy Bird having decided to retire and replacement broght in fr...

September 20, 2023, 5:23 am


Search within

Pages Search Results: